CORRECTION OF VAGINAL MICROBIOCENOSIS IN WOMEN WITH GESTATIONAL DIABETES MELLITUS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To assess the efficacy of vaginorm-C for the correction of vaginal microbiocenosis in women with gestational diabetes mellitus (GDM). Subjects and methods: The study included 45 pregnant women who formed two comparison groups: 1) 30 pregnant women with dietarily compensated GDM; 2) 15 pregnant women with insulin-compensated GDM. The examination standard included clinical and laboratory studies, determination of vaginal acidity (pH) using Careplan VpH test gloves before and after the study, bacterioscopy, molecular biology (PCR), culture (vaginal smear tests for lactobacteria before and after therapy, study of lactobacteria, and evaluation of perinatal outcomes. Results: Within the first days of use of vaginorm-C, more than half (56%) of the patients of the study groups had objective improvement and reduced clinical symptoms of bacterial vaginosis. The vaginal pH value measured by the Careplan VpH system decreased to normal values (<4.5) in about all (93.4%) women included into the protocol. After treatment, the microflora of vaginal secretions became physiological. Virtually all the pregnant women had term deliveries; all babies were born with Apgar scores of 7—8. There were no postpartum infectious complications in the puerperas. Conclusions: The use of vaginorm-C is a safe and effective method to correct vaginal microbiocenosis in women with gestational diabetes and may be used to treat bacterial vaginosis and to prevent postpartum infections in pregnant women with this pathology.

Full Text

Restricted Access

About the authors

O. N ARZHANOVA

D.O. Ott Research Institute of Obstetrics and Gynecology, North-Western Branch of the Russian Academy of Medical Science

Email: arjanova_olga@mail.ru

R. V KAPUSTIN

D.O. Ott Research Institute of Obstetrics and Gynecology, North-Western Branch of the Russian Academy of Medical Science

Email: Kapustin.Roman@gmail.com

References

  1. Байрамова Г.Р., Прилепская В.Н. Современные принципы диагностики и лечения бактериального вагиноза // Рос. вестн. ассоц. акуш.-гин. — 1996. — № 3. — С. 103104.
  2. Громова О.А., Торшин И.Ю., Гарасько Е.А. Молекулярные механизмы разрушения бактериальных пленок при топическом применении аскорбиновой кислоты // Гинекология. - 2010. - Т. 12, № 6. - С. 12-18.
  3. Кира Е.Ф. Бактериальный вагиноз. - СПб.: Н-Л, 2001.
  4. Прилепская В.Н., Довлетханова Э.Р., Байрамова Г.Р. и др. Современный взгляд на вопросы этиологии, патогенеза и лечения бактериального вагиноза // Гинекология. -2010. - Т. 12, № 2. - С. 44-48.
  5. Amsel R., Totten P.A., Spiegel C.A. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations // Am. J. Med. - 1983. - Vol. 74. - P. 14-22.
  6. Eschenbach D.A., Hillier S., Critchlow C. et al. Diagnosis and clinical manifestations of bacterial vaginosis // Am. J. Obstet. Gynecol. - 1988. - Vol. 158. - P. 819-828.
  7. Eschenbach D.A., Davick P.R., Williams B.L. et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis // J. Clin. Microbiol. - 1989. - Vol. 27. - P. 251-256.
  8. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis // N. Engl. J. Med. - 2005. - Vol. 353. - P. 1899-1911.
  9. Hay P.E., Lamont R.F., Taylor-Robinson D. et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage // Br. Med. J. - 1994. -Vol. 308. - P. 295-298.
  10. Hillebrand L., Harmanli O.H., Whiteman V., Khandelwal M. Urinary tract infections in pregnant women with bacterial vaginosis // Am. J. Obstet. Gynecol. - 2002. - Vol. 186. -P. 916-917.
  11. Hillier S.L., Nugent R.P., Eschenbach D.A. et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group // N. Engl. J. Med. - 1995. - Vol. 333. -P. 1737-1742.
  12. Kiss H., Petricevic L., Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery // Br. Med. J. - 2004. -Vol. 329, № 7462. - P. 371.
  13. Kurki T., Sivonen A., Renkonen O.V. et al. Bacterial vaginosis in early pregnancy and pregnancy outcome // Obstet. Gynecol. - 1992. - Vol. 80. - P. 173-177.
  14. Lamont R.F. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth // Br. J.Obstet. Gynaecol. - 2003. - Vol. 110. -P. 71-75.
  15. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation // J. Clin. Microbiol. - 1991. -Vol. 29. - P. 297-301.
  16. Oakeshott P., Hay P., Hay S. et al. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks’ gestation: prospective community based cohort study // Br. Med. J. - 2002. - Vol. 325. -P. 1334.
  17. Petersen E.E., Magnani P. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study // Eur. J. Obstet. Gynecol. Reprod. Biol. - 2004. - Vol. 117, № 1. -P. 70-75.
  18. Petersen E.E., Genet M., Caserini M., Palmieri R. Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled clinical trial // Arzneimittelforschung. - 2011. - Bd 61, № 4. - S. 260-265.
  19. Polatti F., Rampino M., Magnani P., Mascarucci P. Vaginal pH-lowering effect of locally applied vitamin C in subjects with high vaginal pH // Gynecol. Endocrinol. - 2006. -Vol. 22, № 4. - P. 230-234.
  20. Thomason J.L., Gelbart S.M., Anderson R.J. et al. Statistical evaluation of diagnostic criteria for bacterial vaginosis // Am. J. Obstet. Gynecol. - 1990. - Vol. 162. -P. 155-160.
  21. Ugwumadu A., Manyonda, Reid F., Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial // Lancet. -2003. - Vol. 361. - P. 983-988.
  22. Watts D.H., Krohn M.A., Hillier S.L., Eschenbach D.A. Bacterial vaginosis as a risk factor for post-cesarean endometritis // Obstet. Gynecol. - 1990. - Vol. 75. -P. 52-58.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies